In terms of the Company's code of conduct to regulate, monitor and report trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Marksans Pharma has informed that the trading window for dealing in the shares of Marksans Pharma (‘the Company’) by the designated persons of the Company and their immediate relatives will remain closed from Thursday, January 01, 2026 till 48 hours after the declaration of unaudited financial results for the quarter ending December 31, 2025. The date of declaration of financial results will be intimated separately in due course of time. Designated Persons of the Company and their immediate relatives shall not trade in the shares of the Company during the aforesaid period of closure of trading window.
The above information is a part of company’s filings submitted to BSE.
